The scoring system has shown great utility in predicting lymph node invasion in various cancers, but until recently, its use in patients with breast cancer had not been thoroughly explored. 

It also increases cancer detection rates and reduces false positives, according to new work published in the journal Radiology. 

This reduction protocol allows for acceptable lesion visualization while also providing a cautionary cushion when the safety of sequential contrast injections is in question.

Although DBT exams are proven to identify more difficult to detect cancers, especially among women with dense breasts, they also include significantly more images than standard 2D mammograms. 

This is especially true among women younger than 50 and who live in areas considered more socioeconomically disadvantaged, according to new data.

The Class I recall, which is the most serious recall the FDA issues, comes after numerous adverse events and complications linked to the radiographic markers were reported.  

Although studies have shown AI to be effective as a support tool, several have also highlighted issues related to the potential for bias in algorithms that have not been trained on diverse datasets. 

In individuals who have not completed a DEXA scan, head CT conducted for other reasons can offer insight into patients’ frontal bone density, a potential marker of osteoporosis.